The 2011 Leading Pharmaceutical Companies Collaborative Arrangements
Global PDF: US$ 3,900.00
For each company, the report analyzes:
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth
Contains 200 pages
For each company, the report analyzes:
- Major joint venture, distribution, OEM, and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved.
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth
Contains 200 pages
More Publications
The 2012 Leading Agrochemical Companies Collaborative Arrangements
US$ 1,200.00
March 2012
56 pages
The 2011 Leading Chemical Companies Collaborative Arrangements
US$ 1,480.00
September 2011
52 pages
The 2011 Leading Orthopedics Companies Collaborative Arrangements
US$ 1,480.00
September 2011
42 pages
The 2011 Leading Semiconductor Companies Collaborative Arrangements
US$ 1,480.00
October 2010
61 pages
The 2011 Leading Pharmaceutical Companies Comparative Analysis
US$ 680.00
October 2010
-
